HEALTHNBC NEWS
FDA panel recommends Moderna’s mRNA flu shot for older adults
An FDA panel has recommended Moderna’s mRNA flu shot for older adults. The recommendation highlights the potential of mRNA vaccines to be developed and updated quickly to match circulating flu strains later in the year.
Related Signal
Adjacent reporting
- FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
- FDA panel backs first-of-its-kind flu vaccine using mRNA technology
- FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
- STAT+: FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy
- Kerala urged to invest in flu vaccination for the elderly